Ursprung des Netzwerks ersten Grades von Diane Robichaud
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Panthera Dental Inc.
Panthera Dental Inc. Medical SpecialtiesHealth Technology Panthera Dental Inc. engages in prosthetic implant solutions and dental sleep appliances. Its products include metal implant bar, integrated bar, diamart, ReBourke, Copywax, Angulated Screw Channel, and Components and Attachment. The company was founded by Bernard Robichaud, Gabriel Robichaud, and Beatrice Robichaud in 2011 and is headquartered in Quebec, Canada.
5
| Holding Company | Medical Specialties | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Diane Robichaud
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOSYNTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cita NeuroPharmaceuticals, Inc.
Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Director/Board Member | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
RAPID MICRO BIOSYSTEMS, INC. | Industrial Machinery | Director/Board Member | |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor | |
CDP Capital Private Equity
CDP Capital Private Equity Investment ManagersFinance CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London. | Investment Managers | President | |
McGill University | College/University | Doctorate Degree | |
Queen's University | College/University | Graduate Degree | |
University of Ottawa | College/University | Undergraduate Degree Corporate Officer/Principal | |
University of Toronto | College/University | Doctorate Degree | |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Director/Board Member | |
LymphoSign, Inc.
LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Biotechnology | Director/Board Member | |
University of Sherbrooke | College/University | Undergraduate Degree | |
GeneChem Management, Inc.
GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Investment Managers | Private Equity Investor | |
CARDIAnove, Inc.
CARDIAnove, Inc. Medical SpecialtiesHealth Technology CARDIAnove, Inc. engages in the design and development of medical device technologies for temporary and permanent support of the failing heart to improve the quality of life and prolong life of patients suffering from severe congestive heart failure. The company was founded by Conrad Pelletier and Michel Carrier in 1997 and is headquartered in Montréal, Canada. | Medical Specialties | Director/Board Member | |
Cyanamid Canada, Inc. | Private Equity Investor | ||
Smith & Nephew Canada | Private Equity Investor | ||
Emovi, Inc.
Emovi, Inc. Medical/Nursing ServicesHealth Services Emovi, Inc. offers orthopedic services. It offers services to people suffering from knee osteoarthritis, ligament or meniscus tears, patello-femoral syndrome, tendonitis, and biomechanical deficiencies causing pain and disability. The company was founded in 2002 and is headquartered in Montr?al, Canada. | Medical/Nursing Services | Director/Board Member | |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Innovitech, Inc.
Innovitech, Inc. Miscellaneous Commercial ServicesCommercial Services Innovitech, Inc. operates as a business management consultant. Its services include strategic brokering, design and management of game changing projects, and startup coaching. The company was founded in 1990 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
VCIC, Inc.
VCIC, Inc. Investment ManagersFinance CIC Capital Ventures (CIC Capital Ventures) is a venture capital subsidiary of VCIC, Inc founded in 2010. The firm is headquartered in Montréal, Canada. | Investment Managers | Private Equity Investor | |
Ixchelsis Ltd.
Ixchelsis Ltd. BiotechnologyHealth Technology Ixchelsis Ltd. develops oxytocin receptor antagonist for the treatment of premature ejaculation. It operates as a biotechnology company. The firm's product in pipeline IX-01 treats the male sexual health indication and premature ejaculation. The company was founded on July 27, 2011 by Gary John Muirhead, Lizbeth Anne Littlewood, Ian Howard Osterloh and Karl Richard Gibson and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Director/Board Member | |
VG Partners
VG Partners Investment ManagersFinance VG Partners is a private equity investment firm. The private company is based in Toronto, Canada. and has subsidiaries in Canada. | Investment Managers | Corporate Officer/Principal | |
Modulate Therapeutics, Inc.
Modulate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Modulate Therapeutics, Inc. develops a medicine compound designed to re-engage the immune system in order to recognize and eradicate neoplastic disease. The company was founded by September 29, 2015 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Sig.Num
Sig.Num Electronic Production EquipmentElectronic Technology Sig.Num manufactures contactless ECG acquisition system. The firm’s cloud-based platform recognizes and diagnoses early-stage cardiovascular diseases. The company was founded by David Nadezhdin and Deepak Bobby Jain in 2014 and is headquartered in Boucherville, Canada. | Electronic Production Equipment | Chief Executive Officer | |
AurKa Pharma, Inc.
AurKa Pharma, Inc. BiotechnologyHealth Technology AurKa Pharma, Inc. develops medication for cancer treatment. The company was founded by Caroline Fortier and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member | |
Access Vascular, Inc.
Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA. | Medical Specialties | Director/Board Member | |
ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Boreal Ventures
Boreal Ventures Investment ManagersFinance Boreal Ventures (Boreal Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Montreal, Canada. | Investment Managers | Consultant / Advisor | |
TVM Life Science Management, Inc. | Investment Managers | Corporate Officer/Principal | |
Université du Québec à Montréal | College/University | Masters Business Admin |
Statistik
International
Kanada | 35 |
Vereinigte Staaten | 9 |
Schweden | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 21 |
Finance | 11 |
Consumer Services | 7 |
Commercial Services | 3 |
Health Services | 3 |
Operativ
Director/Board Member | 25 |
Private Equity Investor | 6 |
Corporate Officer/Principal | 5 |
Undergraduate Degree | 4 |
Independent Dir/Board Member | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Diane Robichaud
- Unternehmensverbindungen